Sequenom Cash from Investing Quarterly:
-40.12M for Dec. 31, 2012Sequenom Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -40.12M |
| Sept. 30, 2012 | 22.91M |
| June 30, 2012 | 6.421M |
| March 31, 2012 | -3.145M |
| Dec. 31, 2011 | -5.405M |
| Sept. 30, 2011 | 13.55M |
| June 30, 2011 | 11.92M |
| March 31, 2011 | -71.32M |
| Dec. 31, 2010 | -0.51M |
| Sept. 30, 2010 | -0.943M |
| June 30, 2010 | -21.68M |
| March 31, 2010 | 15.23M |
| Dec. 31, 2009 | 16.26M |
| Sept. 30, 2009 | -2.026M |
| June 30, 2009 | -2.163M |
| March 31, 2009 | -4.775M |
| Dec. 31, 2008 | -32.70M |
| Sept. 30, 2008 | -0.614M |
| June 30, 2008 | 7.938M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
SQNM Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Protalix BioTherapeutics | -0.376M |
| Progenics Pharmaceuticals | 0.014M |
| Peregrine Pharmaceuticals | -0.231M |
SQNM Cash from Investing Quarterly Rankings
| Overall |
56th percentile 3335 of 7590 |
| Sector |
27th percentile 469 of 651 in Healthcare |
| Industry |
23rd percentile 182 of 238 in Biotechnology |
SQNM Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -71.32M | Mar 2011 |
| Maximum | 22.91M | Sep 2012 |
| Average | -4.799M |
